IBTFvsIDNA
iShares iBonds Dec 2025 Term Treasury ETF against iShares Genomics Immunology and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBTF | IDNA | |
|---|---|---|
| Expense ratio | 0.070% | 0.47% |
| Assets | $1.4B | $317M |
| Net flow, 1 month | — | +$49M |
| Net flow, 1 year | −$367M | +$106M |
| Return, YTD | — | +56.1% |
| Return, 1 year | 0.0% | +66.5% |
| Avg daily volume | — | 195K |
| Holdings | 32 | 63 |
| Listed | Feb 25, 2020 | Jun 11, 2019 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS